# Jiahui Launches International Cell Therapy Center to Expand Global Access to CAR-T Treatment

- Link: https://www.thailand-business-news.com/pr-news/jiahui-launches-international-cell-therapy-center-to-expand-global-access-to-car-t-treatment
- Published: 2026-10-28T13:41:00+07:00
- Author: PR Newswire

SHANGHAI, Oct. 28, 2026 /PRNewswire/ — Jiahui International Hospital launched Jiahui
International Cell Therapy Center, building on landmark CAR-T cases and multidisciplinary
expertise to serve patients from China and abroad.

The center was unveiled at the inaugural Jiahui International Cell Therapy Summit
on October 23, hosted by Jiahui International Hospital and co-organized by Jiahui
Medical Research & Education Group (J-Med). The event attracted livestream viewing
registrations from 14 countries and regions.

Prof. HAO Siguo, Chief of Hematology at Jiahui International Cancer Center (JICC),
and Prof. XUAN Linli, Chief of Medical Oncology at JICC, joined experts discussing
cellular therapies for blood cancers, solid tumors and autoimmune diseases.

Eric J. Rubin, Editor-in-Chief of the New England Journal of Medicine (NEJM), noted
that NEJM published one research article by Chinese scholars a decade ago, compared
with more than 20 in 2026. Prof. John K. HSIANG, Chairman of Jiahui Health Executive
Committee, highlighted China’s advances in medical innovation.

JICC has established a track record of pioneering CAR-T treatments and encouraging
long-term patient outcomes. In September 2023, JICC treated China’s first international
patient to receive axicabtagene ciloleucel (Axi-Cel) CAR-T therapy, a Singaporean
woman with primary mediastinal large B-cell lymphoma, who remains relapse-free more
than three years after treatment. Building on this milestone, JICC has provided 
CAR-T treatment to patients from Singapore, Hong Kong SAR, Russia, Hungary, New 
Zealand, India, Pakistan, the Maldives and other countries and regions. Following
China’s June 2026 approval of Satri-cel (CT041), the world’s first CAR-T therapy
approved for solid tumors, Jiahui became one of the first institutions to introduce
it clinically and treated the world’s first international recipient—a 59-year-old
New Zealand patient with advanced gastroduodenal cancer.

Prof. Allen WU, President of Jiahui International Hospital, said growing international
demand helped drive the center’s launch. The hospital provides nearly 500,000 patient
visits annually to people from 180 countries and regions. The new center will link
research and clinical care through multidisciplinary expertise and international
patient services.

Read the full story: [https://jiahui.com/en/news/231](https://jiahui.com/en/news/231)

Contact Jiahui International Cancer Center:
Email: [internationaloffice@jiahui.com](https://www.thailand-business-news.com/pr-news/internationaloffice@jiahui.com)
WhatsApp: +852 4619 1904WeChat: Jiahui-GSN

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Jiahui Launches International Cell Therapy Center to Expand Global Access to CAR-T Treatment ](http://www.prnasia.com/story/archive/5083093_AE83093_0?rand=184833)